Fidelity Investments’s SpyGlass Pharma SGP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$18.9K Sell
728
-769
-51% -$18.9K ﹤0.01% 4729
2026
Q2
$33.3K Buy
+1,497
New +$32.5K ﹤0.01% 4476

Other funds holding SGP

Fidelity Investments's SGP Position: Q3 2026 in Review

Fidelity Investments reduced its SpyGlass Pharma (SGP) stake by 51% in Q3 2026, selling an estimated $18.9K and leaving 728 shares worth $18.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4729.

Fidelity Investments first reported a position in SGP in Q2 2026 and has held it in 2 quarters since. The position peaked at $33.3K in Q2 2026. 68 funds tracked by Wall St. Rank hold SGP as of Q3 2026.

  • Fidelity Investments held 728 shares of SpyGlass Pharma worth $18.9K as of Q3 2026.
  • Fidelity Investments sold 769 SpyGlass Pharma shares in Q3 2026, an estimated $18.9K.
  • SpyGlass Pharma made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #4729 holding.
  • Fidelity Investments first reported a position in SpyGlass Pharma in Q2 2026 and has held it in 2 quarters since.
  • Fidelity Investments's SpyGlass Pharma position peaked at $33.3K in Q2 2026.
  • 68 funds tracked by Wall St. Rank held SpyGlass Pharma as of Q3 2026.

Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.